# CLBR Per Initial Cycle With Different Starting Dose in Aged Patients With Poor Ovarian Reservation: 300IU Versus 150IU

> **NCT03914651** · NA · UNKNOWN · sponsor: **Reproductive & Genetic Hospital of CITIC-Xiangya** · enrollment: 260 (estimated)

## Conditions studied

- Infertility

## Interventions

- **DRUG:** 300IU rFSH Gonal-F® starting dose during controlled ovarian stimulation
- **DRUG:** 150IU rFSH Gonal-F® starting dose during controlled ovarian stimulation

## Key facts

- **NCT ID:** NCT03914651
- **Lead sponsor:** Reproductive & Genetic Hospital of CITIC-Xiangya
- **Sponsor class:** OTHER
- **Phase:** NA
- **Study type:** INTERVENTIONAL
- **Status:** UNKNOWN
- **Start date:** 2019-04-23
- **Primary completion:** 2022-12-30
- **Final completion:** 2022-12-30
- **Target enrollment:** 260 (ESTIMATED)
- **Last updated:** 2022-01-12


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT03914651

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT03914651, "CLBR Per Initial Cycle With Different Starting Dose in Aged Patients With Poor Ovarian Reservation: 300IU Versus 150IU". Retrieved via AI Analytics 2026-06-09 from https://api.ai-analytics.org/clinical/NCT03914651. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*